A THRESHOLD ANALYSIS OF THE COST-EFFECTIVENESS OF A DENGUE VACCINE PROGRAM IN YUCATAN, MEXICO

被引：0
|
作者：
de Broucker, Gatien [1 ]
del Campo, Jorge Martin [1 ]
Constenla, Dagna [1 ]
机构：
[1] Int Vaccine Access Ctr, Baltimore, MD USA
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2017年 / 95卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1458
引用
收藏
页码：457 / 457
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness analysis of quadrivalent influenza vaccine in Spain
    Garcia, Amos
    Ortiz de Lejarazu, Raul
    Reina, Jordi
    Callejo, Daniel
    Cuervo, Jesus
    Morano Larragueta, Raul
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (09) : 2269 - 2277
  • [42] A cost-effectiveness analysis of Japanese encephalitis vaccine in Cambodia
    Touch, Sok
    Suraratdecha, Chutima
    Samnang, Chham
    Heng, Seng
    Gazley, Lauren
    Huch, Chea
    Sovann, Ly
    Chhay, Chab Seak
    Soeung, Sann Chan
    VACCINE, 2010, 28 (29) : 4593 - 4599
  • [43] COST-EFFECTIVENESS ANALYSIS OF THE INTRODUCTION OF THE VARICELLA VACCINE IN COLOMBIA
    De la Hoz, F.
    Alvis, N.
    Gamboa, O.
    Castaneda, C.
    Paternina, A.
    VALUE IN HEALTH, 2011, 14 (03) : A118 - A118
  • [44] Cost-Effectiveness Analysis of a Universal Infant Immunization Program with Meningococcal C Conjugate Vaccine in Brazil
    de Soarez, Patricia Coelho
    Sartori, Ana Marli C.
    Lagoa Nobrega, Laura de Andrade
    Itria, Alexander
    Dutilh Novaes, Hillegonda Maria
    VALUE IN HEALTH, 2011, 14 (08) : 1019 - 1027
  • [45] DISEASE IMPACT AND COST-EFFECTIVENESS OF A NEW DENGUE VACCINE TAK003 IN THAILAND
    Shen, J.
    Kharitonova, E.
    Biswal, S.
    Sharma, M.
    Aballea, S.
    Tytula, A.
    Zawieja, J.
    Towle, P.
    Hanley, R.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 130 : S141 - S141
  • [46] COST-EFFECTIVENESS OF HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV-7) IN MEXICO
    Carlos, F.
    Mercado, G.
    Aguirre, A.
    Vargas, A.
    Bierschwale, H.
    VALUE IN HEALTH, 2009, 12 (07) : A420 - A420
  • [47] COST-EFFECTIVENESS IN PROGRAM DELIVERY
    THOMPSON, RS
    TAPLIN, SH
    CARTER, AP
    SCHNITZER, F
    CANCER, 1989, 64 (12) : 2682 - 2689
  • [48] LOOKING FOR A COST-EFFECTIVENESS THRESHOLD IN KOREA
    Ahn, J.
    Kim, Y.
    Shin, S.
    Park, S.
    Song, H.
    Park, J.
    Bae, E.
    VALUE IN HEALTH, 2010, 13 (03) : A88 - A88
  • [49] PHARMAC has no cost-effectiveness threshold
    Metcalfe, Scott
    Rodgers, Alexander
    Werner, Rachel
    Schousboe, Carsten
    NEW ZEALAND MEDICAL JOURNAL, 2012, 125 (1350) : 99 - 101
  • [50] DETERMINATION OF COST-EFFECTIVENESS THRESHOLD FOR MALAYSIA
    Lim, Y. W.
    Shafie, A. A.
    Chua, G. N.
    Hassali, M. A. A.
    VALUE IN HEALTH, 2014, 17 (07) : A438 - A438
12345